High Net Worth Advisory Group LLC
Position in SYRE — Spyre Therapeutics, Inc.
CIK 1919142
NAPLES, FL
Position in SYRE
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$302,640
New position
Shares Held
6,000
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026High Net Worth Advisory Group LLC holds $3,315,565 across 8 Biotechnology names. SYRE ranks #7 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
8,000 | $918,560 | |
| 2 | BLTE |
Belite Bio, Inc
|
3,500 | $558,040 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,500 | $496,305 | |
| 4 | ARGX |
Argenx SE
|
500 | $365,125 | |
| 5 | CYTK |
Cytokinetics Inc
|
5,000 | $329,550 | |
| 6 | NUVL |
Nuvalent, Inc.
|
3,000 | $307,350 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
This page
|
6,000 | $302,640 | |
| 8 | GERN |
Geron Corp
|
25,500 | $37,995 |
All Filings in SYRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $302,640 | 6,000 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||